Las Vegas, NV -- (SBWIRE) -- 10/01/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Globalstar, Inc. (OTCMKTS: GSAT), Magnum Hunter Resources Corp (NYSE:MHR), GT Advanced Technologies Inc (NASDAQ:GTAT), Inovio Pharmaceuticals Inc (NYSEMKT: INO)
Globalstar, Inc. (OTCMKTS: GSAT) managed to keep its gain at 4.81% on above-normal volume of 5.67M shares. The stock settled at $1.09 after floating in a range of $1 to $1.12. Its latest price has reached market capitalization of $727.66 million. Its 52-week range has been $0.25 to $1.12. Globalstar, Inc. provides mobile voice and data communications services through satellite worldwide.
For How Long GSAT will fight for Profitability? Read This Trend Analysis report
Magnum Hunter Resources Corp (NYSE:MHR) traded down on a volume of 5.60 million, higher than its standard daily volume. Shares have dropped -2.53% to $6.17. Over the last twelve months, the stock has gained 38.96% and faced a worst price of $2.37. Magnum Hunter Resources Corporation, an independent oil and gas company, engages in the exploration, exploitation, acquisition, development, and production of crude oil, natural gas, and natural gas liquid resources in the United States and Canada.
Has MHR Found The Bottom And Ready To Gain Momentum? Find Out Here
GT Advanced Technologies Inc (NASDAQ:GTAT) settled 1.49% higher at $8.51 on above-normal volume of 5.58M shares during the last trading day. The stock has its 12-month high at $8.84 and 52-week low price was $2.61. It traded in a range of $8.05 to $8.64 during the last trading day. GT Advanced Technologies Inc. provides crystal growth equipment and solutions for the solar, light emitting diode (LED), and electronics industries worldwide. The company operates through three segments: Polysilicon; Photovoltaic (PV); and Sapphire.
Why Should Investors Buy GTAT After the Recent Fall? Just Go Here and Find Out
In the last trading session, Inovio Pharmaceuticals Inc (NYSEMKT: INO) was down on low volume, trading at a volume of5.36M versus its average daily volume of 9.97 million shares. At $2.07, the stock has attained market capitalization of 393.10 million. Inovio Pharmaceuticals, Inc., together with its subsidiaries, engages in the discovery and development of synthetic vaccines and immune therapies focusing on cancers and infectious diseases.
Why Should Investors Buy INO After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)